Livzon Pharmaceutical Group (SZSE:000513) EPS (Basic) : ¥2.13 (TTM As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group EPS (Basic)?

Livzon Pharmaceutical Group's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was ¥0.65. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.13.

Livzon Pharmaceutical Group's EPS (Diluted) for the three months ended in Mar. 2024 was ¥0.65. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.13.

Livzon Pharmaceutical Group's EPS without NRI for the three months ended in Mar. 2024 was ¥0.66. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 2.38.

During the past 12 months, Livzon Pharmaceutical Group's average EPS without NRIGrowth Rate was 7.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 9.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 15.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 16.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Livzon Pharmaceutical Group's highest 3-Year average EPS without NRI Growth Rate was 255.70% per year. The lowest was -75.60% per year. And the median was 17.30% per year.

Livzon Pharmaceutical Group EPS (Basic) Historical Data

The historical data trend for Livzon Pharmaceutical Group's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group EPS (Basic) Chart

Livzon Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

1.39

1.83

1.90

2.04

2.10

Livzon Pharmaceutical Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial															0.62	0.60	0.50	0.38	0.65

Livzon Pharmaceutical Group EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Livzon Pharmaceutical Group's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(1953.651	-	0)	/	930.310
	=	2.10

Livzon Pharmaceutical Group's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(607.824	-	0)	/	935.114
	=	0.65

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.13

Livzon Pharmaceutical Group (SZSE:000513) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Livzon Pharmaceutical Group EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Livzon Pharmaceutical Group (SZSE:000513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » EPS (Basic)

Traded in Other Exchanges

01513:Hong Kong LP6:Germany

Address

38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090

Website

https://www.livzon.com.cn

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Executives

Xu Guo Xiang	Directors, executives
Tang Yang Gang	Directors, executives
Yang Liang	Secretary Dong
Si Yan Xia	Executives
Zhou Peng	Executives
Huang Yu Xuan	Executives
Huang Hua Min	Supervisors
Yang Dai Hong	Executives
Wang Wu Ping	Executives

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines